Neurocrine Biosciences
NBIX
#1334
Rank
NZ$29.11 B
Marketcap
NZ$289.54
Share price
2.09%
Change (1 day)
39.53%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

We have found no dividend history for this company